Early Detection

Diana’s Fibroid Foundation / Archive by Category Early Detection

Developing Circulating Tumor DNA (ctDNA)-Based Early Detection for Leiomyosarcoma (LMS)

Investigators: Brian D. Crompton, MD, PhD; Suzanne George, MDInstitution: Dana-Farber Cancer Institute, Boston Children’s Hospital Clinical Challenge Uterine leiomyosarcoma are rare, highly aggressive malignancies that can mimic benign fibroids. Because... read more →

Genomic & Clinical Analysis of Leiomyosarcoma (LMS) via the Count Me In LMS project

Lead Investigators: Suzanne George, MD; Katherine Janeway, MDInstitution: Dana-Farber Cancer Institute, Broad Institute Clinical Challenge Leiomyosarcoma is a rare, aggressive smooth-muscle cancer with limited datasets, slowing discovery of biomarkers and... read more →

January 13, 2026
admin
No Comments
Early Detection, Future Funding Need, Scientific Discovery

Improving Diagnostic Techniques to Distinguish Uterine Sarcomas from Leiomyomas

DFF is collaborating with Dana-Farber Cancer Institute to validate a practical MRI-based tool to distinguish benign fibroids from deadly uterine sarcomas before surgery.Early detection saves live and this work brings... read more →